These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 888468)

  • 21. Hexobarbital sleeping time in the rat: effects of isolation and lesions of the locus coeruleus.
    Czlonkowski A; Kostowski W; Jerlicz M
    Pol J Pharmacol Pharm; 1976; 28(6):609-13. PubMed ID: 1034923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Investigations on the mechanism of enzyme induction in rats and mice. V. Influence of the gonads on 1-ascorbic acid normal excretion and its increase as well as on hexobarbital sleep duration and its reduction by barbital].
    Klinger W; Koch M; Kramer B
    Acta Biol Med Ger; 1965; 15(6):700-6. PubMed ID: 5884597
    [No Abstract]   [Full Text] [Related]  

  • 23. Interaction between manganese and phenobarbital on hexobarbital hypnosis in the male rat.
    Deimling MJ; Schnell RC
    Res Commun Chem Pathol Pharmacol; 1983 Jul; 41(1):165-8. PubMed ID: 6622829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Influence of an antiandrogen on the sleeping period of male and female mice and rats following administration of hexobarbital].
    Hempel R
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 257(1):27. PubMed ID: 4231840
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of pyriditol on drug metabolism].
    Avakumov VM; Kovler MA
    Farmakol Toksikol; 1980; 43(4):417-21. PubMed ID: 7192219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lethality, hexobarbital narcosis and behavior in rats exposed to atrazine, bentazon or molinate.
    Ugazio G; Bosio A; Burdino E; Ghigo L; Nebbia C
    Res Commun Chem Pathol Pharmacol; 1991 Dec; 74(3):349-61. PubMed ID: 1775725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The binding of hexobarbital and aniline to cytochrome P-450 of liver microsomes from control and phenobarbital-treated rats of different ages.
    Müller D; Klinger W
    Acta Biol Med Ger; 1976; 35(5):627-33. PubMed ID: 983613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The hexobarbital sleeping time in a pharmacologico-toxicological experiment with special reference to age and chronobiologically-limited variations in Wistar rat strain WIST/Lppt].
    Lange N; Kühnert M; Ebbinghaus F; Hille G; Wolf U
    Dtsch Tierarztl Wochenschr; 1992 Apr; 99(4):145-8. PubMed ID: 1606896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of adrenal dysfunction on activity and pharmacokinetics of some neutropic drugs. II. Influence of chronic premedication with dexamethasone on pharmacodynamic activity and pharmacokinetics of drugs.
    Cenajek D; Szczawinńska K
    Arch Immunol Ther Exp (Warsz); 1975; 23(6):825-30. PubMed ID: 1220634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of drug metabolism. VI. Inhibition of hexobarbital metabolism in the isolated perfused liver of the rat.
    Stitzel RE; Tephly TR; Mannering GJ
    Mol Pharmacol; 1968 Jan; 4(1):15-9. PubMed ID: 5640777
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of barbiturates on rats of different ages].
    Kuhlmann K; Oduah M; Coper H
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 265(4):310-20. PubMed ID: 4244608
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of chronic treatment with therapeutically useful antibiotics on the response of certain pharmacologic agents in the rat.
    Prabhu VG
    J Am Osteopath Assoc; 1970 Jun; 69(10):1022-3. PubMed ID: 5201419
    [No Abstract]   [Full Text] [Related]  

  • 33. [The effect of the calcium channel blockers cinnarizine and flunarizine on the duration of hexobarbital-induced sleep i rats].
    Marazova KD; Lozeva VG; Belcheva-Beronova A
    Eksp Klin Farmakol; 1993; 56(2):16-8. PubMed ID: 8348027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of x-irradiation on the hexobarbital-metabolizing enzyme system of rat liver.
    Yam KM; DuBois KP
    Radiat Res; 1967 Jun; 31(2):315-26. PubMed ID: 6025865
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of model traumatic injury on hepatic drug metabolism in the rat. II. In vivo metabolism of hexobarbital and zoxazolamine.
    Griffeth LK; Rosen GM; Rauckman EJ
    Drug Metab Dispos; 1984; 12(5):582-7. PubMed ID: 6149908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of hepatic drug metabolism by cyclic 3',5'-adenosine monophosphate.
    Weiner M; Buterbaugh GG; Blake DA
    Res Commun Chem Pathol Pharmacol; 1972 Mar; 3(2):249-63. PubMed ID: 4372659
    [No Abstract]   [Full Text] [Related]  

  • 37. Stereoselective hydroxylation of hexobarbital enantiomers by rat liver microsomes.
    Miyano K; Fujii Y; Toki S
    Drug Metab Dispos; 1980; 8(2):104-10. PubMed ID: 6103782
    [No Abstract]   [Full Text] [Related]  

  • 38. Loss of substrate binding capacity of the hepatic microsomal cytochrome P-450 in Fasciola hepatica infected rats: toxicological implications.
    Maffei Facino R; Carini M
    Farmaco Sci; 1982 Mar; 37(3):184-91. PubMed ID: 6802668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of cimetidine and ranitidine on drug metabolism of the liver].
    Homann J; Paul F; Kratz F; Leimenstoll G; Kamenisch W; Matthes KJ
    Med Welt; 1983 Mar; 34(10):313-5. PubMed ID: 6302436
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of methyl mercury pretreatment on the duration of hexobarbital hypnosis on rat.
    Pekkanen TJ; Pekkarinen K
    Acta Vet Scand; 1972; 13(1):149-50. PubMed ID: 5023031
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.